San Diego, CA, United States of America

Glysens Incorporated

Calculating rank
USPTO Granted Patents = 9


Trademarks = 1

Forward Citations = 85

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Joseph Y Lucisano (9 out of 28 patents)

silverMedal Timothy Routh (4 out of 6 patents)

bronzeMedal Joe Lin (4 out of 7 patents)

4.  Piyush Gupta (3 out of 334 patents)

5.  Bahman Javidi (2 out of 2 patents)

6.  Lev Kurbanyan (2 out of 2 patents)

7.  Bradley Walker (2 out of 2 patents)

8.  Mark B Catlin (2 out of 6 patents)

9.  Jonathan Wilensky (1 out of 1 patent)

10.  Robert Engler (1 out of 1 patent)

11.  William J Choi (1 out of 1 patent)

12.  Payton C Chu (1 out of 1 patent)

13.  Thomas Germain Wallner (1 out of 6 patents)

14.  Timothy L Routh (0 patent)

15.  Joe T Lin (0 patent)


9 patents:

Company Overview
Glysens Incorporated is a medical technology company focused on developing innovative solutions for continuous glucose monitoring. Their flagship product, the GlySens Implantable Continuous Glucose Monitoring System, provides accurate and reliable glucose readings for people with diabetes. The company's mission is to improve the lives of patients by providing them with the tools they need to manage their condition effectively.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

9 Patents

#580 in San Diego, CA

#7,751 in California

#32,624 in US

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 85

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glysens Incorporated. Retrieved from https://idiyas.com/company/glysens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…